President and Chief Academic Officer
Allina Health Cancer Institute, Allina Health System, United States
Badrinath R. Konety, MD, MBA, FACS, FRCS (Glasg) is currently serving as the President, Allina Health Cancer Institute, Minneapolis and Chief Academic Officer for Allina Health. He has previously served as The Henry P. Russe, MD, Dean of Rush University Medical College and Senior Vice President for Clinical Affairs, Rush University System for Health.
Dr. Konety has held multiple leadership positions during his tenure at the University of Minnesota, UCSF and University of Iowa. These include serving as Chair of the Dept of Urology (Univ. of Minnesota) Associate Director for Clinical Affairs at the Masonic Cancer Center .
Dr. Konety completed his residency, MBA and American Foundation for Urologic Disease Research Scholar fellowship at the University of Pittsburgh. He completed his urologic oncology fellowship at Memorial Sloan Kettering Cancer Center. Dr. Konety has authored or co-authored over 350 publications, numerous book chapters and edited two books. He has been received funding from the Department of Defense, National Institutes of Health, American Geriatrics Society, and Center for Disease Control.
Dr. Konety is a former President of the SIU, the Society of Academic Urology and the Minnesota Urologic Society. He has been the Associate Editor of the Journal of Urology. He is also a member of several other editorial boards and the executive leadership of several societies. He has received the Jahnigen Career Development Scholar Award (American Geriatric Society), the Ferdinand Valentine fellowship (New York Academy of Medicine), Sushruta Award (IAUA), the David Utz award (Minnesota Urologic Society) and the Felix Guyon Medal (SIU). He was also recognized by election as a Fellow of the Royal College of Physicians and Surgeons of Glasgow.
SYMP-01: Biomarkers for Bladder Cancer-Impact on Treatment Decision
Wednesday, October 29, 2025
13:00 - 13:15 GMT+0
SURG-03: Surgery Day - Session Three - Uro-Oncology and Focal Therapy
Thursday, October 30, 2025
14:00 - 15:50 GMT+0
IC-04: Avoiding Lymphorrhea without compromising the LND
Friday, October 31, 2025
11:35 - 11:50 GMT+0
Saturday, November 1, 2025
11:15 - 12:45 GMT+0
SYMP-29: Pathological or imaging/cysto applications of AI in NMIBC
Saturday, November 1, 2025
11:15 - 11:25 GMT+0